Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 3 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge.
N Engl J Med. 2022 Sep 1;387(9):790-798. doi: 10.1056/NEJMoa2204919. Epub 2022 Aug 24.
N Engl J Med. 2022.
PMID: 36001529
Free PMC article.
BACKGROUND: The oral protease inhibitor nirmatrelvir has shown substantial efficacy in high-risk, unvaccinated patients infected with the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Data regarding the effectiveness of nirmatre …
BACKGROUND: The oral protease inhibitor nirmatrelvir has shown substantial efficacy in high-risk, unvaccinated patients infected with the …
Therapeutic Drug Monitoring of Infliximab in Acute Severe Ulcerative Colitis.
Gordon BL, Battat R.
Gordon BL, et al.
J Clin Med. 2023 May 10;12(10):3378. doi: 10.3390/jcm12103378.
J Clin Med. 2023.
PMID: 37240484
Free PMC article.
Review.
Item in Clipboard
The Impact of Confounders on Symptom-Endoscopic Discordances in Crohn's Disease.
Rajan A, Pan Y, Mahtani P, Niec R, Longman R, Gerber J, Lukin D, Scherl E, Battat R.
Rajan A, et al.
Crohns Colitis 360. 2023 Mar 28;5(2):otad017. doi: 10.1093/crocol/otad017. eCollection 2023 Apr.
Crohns Colitis 360. 2023.
PMID: 37016720
Free PMC article.
Item in Clipboard
Higher Adalimumab Trough Levels Are Associated with Histologic Remission and Mucosal Healing in Inflammatory Bowel Disease.
Wong R, Qin L, Pan Y, Mahtani P, Longman R, Lukin D, Scherl E, Battat R.
Wong R, et al.
J Clin Med. 2023 Oct 27;12(21):6796. doi: 10.3390/jcm12216796.
J Clin Med. 2023.
PMID: 37959261
Free PMC article.
Symptoms correlated weakly and non-significantly with both histologic (RHI) scores (r = 0.25, p = 0.2) and adalimumab concentrations (r = 0.05, p = 0.8). (4) The current study demonstrated that higher serum adalimumab concentrations (16.3 ug/mL) are needed for histo …
Symptoms correlated weakly and non-significantly with both histologic (RHI) scores (r = 0.25, p = 0.2) and adalimumab concentrations …
Item in Clipboard
Cite
Cite